The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens

NAActive, not recruitingINTERVENTIONAL
Enrollment

249

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions
Myopia
Interventions
DEVICE

Model-A Novel spectacle lens

Model-A Novel spectacle lenses will be given to 1 arm to wear for 36 months

DEVICE

Model-B Novel spectacle lens

Model-B Novel spectacle lenses will be given to 1 arm to wear for 36 months

DEVICE

Single vision spectacle lens

Single Vision Spectacle lenses will be given to 1 arm to wear for 36 months

Trial Locations (5)

Unknown

Beijing Tongren Hospital, Capital Medical University, Beijing

Guangzhou Aier Eye Hospital, Guangzhou

Eye and ENT Hospital of Fudan University, Shanghai

Shengyang He Eye Specialist Hospital, Shengyang

Tianjin Medical University Eye Hospital, Tianjin

All Listed Sponsors
lead

HOYA Lens Thailand LTD.

INDUSTRY

NCT05886348 - The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens | Biotech Hunter | Biotech Hunter